Guardian Therapeutics
Cambridge, US · Founded 2017 · Delaware LLC
Founders & leadership
JC
James C. Gilbert, MDExecutive Officer and Manager
CB
Christa Badger SchmidtManager
Reported raises · per SEC filings
Form D private placements$30M disclosed across 2 rounds · 2018
▶$20MraisedAug 2018 · 1 investors · BiotechnologyRule 506(b)
▶$20MraisedAug 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Clarke AtwellExecutive Officer
- Christa Badger SchmidtExecutive Officer
- James C. Gilbert, MDExecutive Officer
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Aug 2018
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
▶$10MraisedFeb 2018 · 1 investors · BiotechnologyRule 506(b)
▶$10MraisedFeb 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James C. Gilbert, MDExecutive Officer
- Christa Badger SchmidtExecutive Officer
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Feb 2018
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Guardian Therapeutics raised?
- Guardian Therapeutics has disclosed $30M raised across 2 rounds.
- Where is Guardian Therapeutics headquartered?
- Guardian Therapeutics is headquartered in Cambridge, US.